Request Trial
pirke / Shutterstock.com
26 March 2024NewsMedTechMarisa Woutersen

Judge tears into ‘safe harbour’ ruling in heart valve system case

Judge’s dissenting opinion challenges the interpretation of the safe harbour provision by the US Court of Appeals for the Federal Circuit | Decision concerns Meril's importation of transcatheter heart valve systems in a dispute with Edwards Lifesciences | Court majority upheld the district court's ruling favouring Meril.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Week Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Atif Choudhury at achoudhury@lifesciencesipreview.com 


More on this story

MedTech
Oura targets Ultrahuman’s redesigned smart ring following import ban
29 October 2026   The Finnish wearable tech company strikes again after the Indian rival’s redesigned ring cleared US Customs, with one of Oura’s asserted patents issued just two days earlier.
MedTech
Meril turns the tables on Edwards with European patent revocation
29 October 2026   Despite earlier wins at the UPC and EPO, a key heart valve patent has been revoked on appeal, with the latest ruling highlighting diverging approaches to patent validity in Europe and raising questions ahead of a separate UPC appeal.
MedTech
HeartFlow targets AI cardiac imaging rival over patents and trade secrets
27 October 2026   The 179-page lawsuit alleges that a Boston-based company used patented technology and confidential information from former employees to develop a competing cardiac imaging product.


Editor's picks

WATCH: Medmix global IP head on building business-focused IP teams
In-house counsel
WATCH: Medmix global IP head on building business-focused IP teams
21 October 2026

Editor's picks

In-house counsel
WATCH: Medmix global IP head on building business-focused IP teams
21 October 2026
MedTech
Boston Scientific expands dispute with J&J unit over cardiac-access technology
12 October 2026
Pharma
Dr Reddy’s v Boehringer: Data gaps take centre stage in courtroom
6 October 2026
In-house counsel
WATCH: Genevant IP director on tackling UPC-EPO opposition divide
1 October 2026
Pharma
Lilly loses Fed Circ rehearing bid, sparking enablement questions
1 October 2026
Pharma
Takeda sees off UK challenge to Elvanse SPC
28 September 2026

More features

Oura targets Ultrahuman’s redesigned smart ring following import ban
Weil collapse leaves IP talent facing uncertain future after major expansion
Meril turns the tables on Edwards with European patent revocation
Latham lands pharma and tech expert in London
Regeneron and Amgen call a truce on two Eylea biosimilar patents
HeartFlow targets AI cardiac imaging rival over patents and trade secrets
Womble Bond Dickinson loses trio of partners to US rival
‘Companies that don’t leverage AI will struggle to keep up’: Umicore IP chief